WilmerHale represented the underwriters in the public offering of 6,095,000 shares of common stock of Forma Therapeutics Holdings, Inc., a clinical stage biopharmaceutical company, at a public offering price per share of $45.25. The shares of common stock sold reflected the full exercise of the underwriters’ option to purchase additional shares, and the gross proceeds to the company were $275.8 million, before deducting underwriting discounts and offering expenses. The offering priced on December 10, 2020 and closed on December 15, 2020.

The WilmerHale team advising the underwriters consisted of Lisa Firenze, Bruce Manheim, Colleen Superko, Michael Lopes, Jason Hyatt, Elizabeth Brasher and Heidi Treiber.